Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Cleary

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|April 1, 1979
Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case originD N Gerding, A E Buxton, R A Hughes, et al.
Journal of Clinical Microbiology|November 1, 1990
Characterization of prototype and clinically defined strains of Streptococcus suis by genomic fingerprintingJ D Mogollon, C Pijoan, M P Murtaugh, et al.
Molecular Microbiology|February 27, 1999
High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangementsP E Dombek, D Cue, J Sedgewick, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Group A and group B streptococcal vaccine development. A round table presentationJ B Dale, P P Cleary, V A Fischetti, et al.
Biochimica Et Biophysica Acta|August 30, 1991
Purification of the proteinase from group B streptococci that inactivates human C5aJ F Bohnsack, X N Zhou, P A Williams, et al.
Journal of Clinical Microbiology|September 1, 1990
Comparison of epidemic and endemic group G streptococci by restriction enzyme analysisN J Martin, E L Kaplan, M A Gerber, et al.
Lancet (London, England)|February 29, 1992
Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980sP P Cleary, E L Kaplan, J P Handley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2000
A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexesD Cue, S O Southern, P J Southern, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1988
Group B streptococci inhibit the chemotactic activity of the fifth component of complementH R Hill, J F Bohnsack, E Z Morris, et al.
Pediatrics|May 1, 1991
Community-wide outbreak of group G streptococcal pharyngitisM A Gerber, M F Randolph, N J Martin, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|April 1, 1979
Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case originD N Gerding, A E Buxton, R A Hughes, et al.
Journal of Clinical Microbiology|November 1, 1990
Characterization of prototype and clinically defined strains of Streptococcus suis by genomic fingerprintingJ D Mogollon, C Pijoan, M P Murtaugh, et al.
Molecular Microbiology|February 27, 1999
High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangementsP E Dombek, D Cue, J Sedgewick, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Group A and group B streptococcal vaccine development. A round table presentationJ B Dale, P P Cleary, V A Fischetti, et al.
Biochimica Et Biophysica Acta|August 30, 1991
Purification of the proteinase from group B streptococci that inactivates human C5aJ F Bohnsack, X N Zhou, P A Williams, et al.
Journal of Clinical Microbiology|September 1, 1990
Comparison of epidemic and endemic group G streptococci by restriction enzyme analysisN J Martin, E L Kaplan, M A Gerber, et al.
Lancet (London, England)|February 29, 1992
Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980sP P Cleary, E L Kaplan, J P Handley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2000
A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexesD Cue, S O Southern, P J Southern, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1988
Group B streptococci inhibit the chemotactic activity of the fifth component of complementH R Hill, J F Bohnsack, E Z Morris, et al.
Pediatrics|May 1, 1991
Community-wide outbreak of group G streptococcal pharyngitisM A Gerber, M F Randolph, N J Martin, et al.
Pageof 9